JPRN-UMIN000051180已完成Unknown
The change in FIB-4 in Japanese patients with type 2 diabetes treated by a fixed-ratio combination therapy of insulin degludec and liraglutide (IDegLira) - The change in FIB-4 in Japanese patients with type 2 diabetes treated by a fixed-ratio combination therapy of insulin degludec and liraglutide (IDegLira)
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 137
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •IDegLira was started at dose >16 dose steps IDegLira had already been administered at the initial consultation Antidiabetic agents other than IDegLira were changed during observation period Patients who discontinued treatment during observation period Patients who were transport to other hospitals during observation period
研究者
相似试验
招募中
不适用
Features in Japanese Patients with Inflammatory Bowel Diseases : A multicenter prospective long observational studyInflammatory Bowel DiseaseJPRN-UMIN000039131Chiba University1,000
已完成
不适用
Japan Fabry Disease Registry and Cohort StudyFabry diseaseJPRN-UMIN000009786Japan Fabry Nephropathy Study Group200
尚未招募
不适用
Fibrosis-4 Score (FIB-4) screening in patients with diabetes mellitus by a retrospective analysis of HbA1c laboratory requisitionsE11Type 2 diabetes mellitusDRKS00032154niversität Leipzig, Bereich Hepatologie750,000
已完成
2 期
Japanese phase II study in untreated patients with CD20 positive B-cell non-Hodgkin's lymphoma evaluating safety of 90-minute infusion of rituximab.CD20 positive follicular lymphoma or diffuse large B-cell lymphoma.JPRN-jRCT2080223607ZENYAKU KOGYO CO., LTD.33
未知
2 期
Phase II Study of S-555739 in Patients with Japanese Cedar Pollinosis in an Environmental Challenge ChamberJPRN-jRCT2080221936SHIONOGI & CO., LTD.